Patent details

Basic Information

Publication number:

91161

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP903022697

Legal Status:

Expired

Application number:

91161

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/04/294/001-012

Marketing Authorization Type:

Marketing Authorization Date:

22/10/2004

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Dates

Filing date:

11/04/2005

First Marketing Authorization date:

22/10/2004

Grant date:

13/06/2005

Activation date:

02/03/2010

Publication date:

13/06/2005

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

02/03/2015

SPC Extension Expiration:

02/03/2015

Rejection date:

Withdrawal date:

Owner

From:

02/05/2013

 

 

Name:

MERUS LABS LUXCO SÀRL

Address:

208 VAL DES BONS MALADES, 2121, LUXEMBOURG, Luxembourg (LU)

History of Owners

From:

11/04/2005

To:

01/05/2013

Name:

NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD

Address:

HURST HOLME, 12 TROTT ROAD, HAMILTON HM 11, BERMUDA, United Kingdom (GB)

Agent

1

Name:

MARKS & CLERK LLP

From:

02/05/2013

Address:

BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

2

Name:

ERNEST T. FREYLINGER,ARMAND SCHMITT, PIERRE KIHN, J. BEISSEL, R. LAMBERT, P. OCVIRK, O. LAIDEBEUR

From:

11/04/2005

Address:

ROUTE D'ARLON 234, 8001, STRASSEN, Luxembourg (LU)

To:

01/05/2013

Inventor

1

Name:

Mackenzie Alexander Roderick, Dr.

Address:

United Kingdom (GB)

2

Name:

Cross Peter Edward, Dr.

Address:

United Kingdom (GB)

Filing date	Document type	Number of pages
12/08/2022	Request For Change	1
02/09/2022	Outgoing Correspondence	56